918water-solubledrugswithintheirhydrophobiccorethanmostsurfactantmicelles.Sincemostofpolymericmicellesareintendedtobeadministeredintravenously[20],thedevelopmentofpolymericmicellesviatheoralroutehasbeenattractedattention[16,21,22].Francisetal.[9]reportedthatthepolymericmicellesexhibitedhighsta-bilityingastricandintestinal uidsandnosigni cantcytotoxicitytowardCaco-2cells,andtheapical-to-basalpermeabilityofCyclosporineA(CyA)acrossCaco-2cellsincreasedsigni cantlywhenloadedinpolymericmicellescomparedtofreeCyA.However,theabsorptionenhance-mentofdrugloadedinpolymericmicellesbyoraldeliverytoratshasremainedelusive.Thesepromptedustoinves-tigatethesuitabilityofpolymericmicellesascarrierstoenhancetheoralabsorptionofBCSClassII(i.e.,lowsolubility–highpermeability)drugs.
Inthepresentstudy,CyAwhichbelongstoBCSClassIIwasselectedasamodeldrug.CyAisahighlylipo-philiccyclicundecapeptideof11aminoacids,andahighlyeffectiveimmunosuppressiveagentwhichiswidelyusedinclinicforpreventionofallograftrejectionafterorgantransplantationandtreatmentofautoimmunedisease[23–25].Nevertheless,theoralbioavailabilityofCyAislowandirregular[26]duetothelargemolecularweight(1202Da),lowsolubilityinwater(23lg/mLatroomtemperature)[27],veryhighlipophilicity(logP=2.92)[28],asubstrateofP-glycoprotein,andvulnerabletointestinalmucosaandliverP4503A4.ThecurrentlyavailableoralformulationofCyAisintheformofamicroemulsioncontainingahighconcentrationofCremophorRH40whichhasbeenreportedtoinduceundesirablesideeffects,suchasnephrotoxicityandinductionofanaphylacticreactionsinsensitizedpatients,althoughtheoralabsorptionofCyAwasremarkablyenhanced.Consequently,therehasbeenanurgentrequirementtodesignanddevelopanoveldosageformofCyAaimedatdecreasingthesideeffectsofthecurrentformulationwhilepreservingthebioavailabilityofthedrug.
ThepurposesofthisstudyweretodesignandevaluateCyA-loadedpolymericmicellesinvitro.Therefore,mono-methoxypoly(ethyleneglycol)–poly(lactide)(mPEG–PLA)withmolecularweightof2500,5000,10000,and15000DaforPLAblockwerestrategicallydesignedandsynthesizedbyring-openingpolymerizationofD,L-dilactide(D,L-LA)inthepresenceofmPEGwithmolecularweightof5000Da,respectively.Themicellespreparation,CyAsolubilization,andmicellespropertieswereinvestigatedbythesizemea-surement,drugloadingcontent(LC),encapsulationef -ciency(EE),stabilityingastrointestinaltract,andinvitrodrugrelease.IntestinalabsorptioninsituandexvivoofCyA-loadedpolymericmicelleswasassessed,respectively.
123
NanoscaleResLett(2010)5:917–925
MaterialsandMethodsMaterials
CyclosporineA(CyA)waskindlydonatedfromHangzhouZhongmeiHuadongPharmaceuticalCo.Ltd.,China.Monomethoxypoly(ethyleneglycol)withmolecularweightof5000Da(mPEG)andstannous2-ethylhexanoatewerepurchasedfromSigma.3,6-dimethyl-1,4-dioxane-2,5-dione(D,L-lactide)wasobtainedfromDaigangBio-logicalTechnologyCo.Ltd.,China.Allotherreagentswereofanalyticalgrade,exceptthoseforHPLCassaywhichwereofHPLCgrade.Animals
Sprague-Dawley(SD)ratswereobtainedfromAnimalsCenterofPekingUniversityHealthScienceCenter.Allanimalswereprovidedwithstandardfoodandwateradlibitumandwereexposedtoalternating12-hperiodsoflightanddarkness.Temperatureandrelativehumidityweremaintainedat25°Cand50%,respectively.AllcareandhandlingofanimalswereperformedwiththeapprovalofInstitutionalAuthorityforLaboratoryAnimalCareofPekingUniversity.
PredictionofCompatibilityBetweenPolymersandtheDrug
Compatibilitybetweenpolymersandthedrugwaspre-dictedbyinteractionparameterscalculatedfrompartialsolubilityparameter[29].ThesolubilityparameterwasobtainedbyHansen’sapproach,wherethepartialsolubilityparameters(dd,dh,anddp)forthedrug(CyA)andarangeofbiodegradablepolymers(PLA,PLGA,andPCL)werecalculatedbythegroupcontributionmethod(GCM)[30]usingEqs.1,2,and3presentedbelow.dPFd¼
dið1Þ
qV PF2
dpi
p¼ð2Þp dP
VFh¼
hi
V
ð3Þ
whereFdi,Fpi,andFhirefertothespeci cfunctionalgroupcontributionsvanderWaalsdispersionforces(Fdi),dipole–dipoleinteractions(Fpi),andhydrogenbonding(Fhi),respectively.WhiletheinteractionparameterbetweendrugandpolymerwascalculatedaccordingtoEqs.4and5presentedbelow:
[9], at the same time nanocarriers can make the drugs targeted and lower...2.3. Preparation and characterization of drug loaded micelle NPs Micelle NPs...
[9], at the same time nanocarriers can make the drugs targeted and lower...2.3. Preparation and characterization of drug loaded micelle NPs Micelle NPs...
热门文档